Neurogene (NGNE)
NASDAQ:NGNE
US Market
Holding NGNE?
Track your performance easily

Neurogene (NGNE) Financial Statements

438 Followers

Neurogene Financial Overview

Neurogene's market cap is currently ―. The company's EPS TTM is $-3.709; its P/E ratio is -11.87; Neurogene is scheduled to report earnings on August 9, 2024, and the estimated EPS forecast is $-1.05. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 925.00K----
Gross Profit$ 925.00K----
EBIT$ -18.49M$ -16.92M$ -28.89M$ -3.48M$ -3.07M
EBITDA$ -17.23M$ -16.55M$ -25.15M$ -2.44M-
Net Income Common Stockholders$ -18.49M$ -16.92M$ -15.50M$ -4.53M$ -2.08M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 153.91M$ 169.53M$ 197.16M$ 78.51M$ 82.06M
Total Assets$ 179.82M$ 195.35M$ 222.57M$ 89.59M$ 94.00M
Total Debt$ 13.79M$ 14.41M$ 14.97M$ 10.69M$ 11.04M
Net Debt$ -140.12M$ -155.13M$ -182.19M$ -67.81M$ -71.02M
Total Liabilities$ 24.81M$ 24.57M$ 36.55M$ 14.35M$ 14.43M
Stockholders Equity$ 155.01M$ 170.78M$ 186.02M$ 75.23M$ 79.58M
Cash Flow-
Free Cash Flow$ -16.26M$ -21.77M$ -31.93M$ -4.27M-
Operating Cash Flow$ -15.80M$ -21.70M$ -30.05M$ -4.27M$ -4.05M
Investing Cash Flow$ -23.61M$ 29.93M$ 16.96M$ -1.61M$ -411.00K
Financing Cash Flow$ 399.00K$ -6.52M$ 92.84M$ -1.00K$ -294.00K
Currency in USD

Neurogene Earnings and Revenue History

Neurogene Debt to Assets

Neurogene Cash Flow

Neurogene Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis